| Efficacy, Safety and Tolerability of NVA237 in Patients With Chronic Obstructive Pulmonary Disease (NCT01566604) | Novartis Pharmaceuticals | 2012-03-01 |
| Bioavailability Study of SYN006, Pulmicort pMDI and Meptin Air in Healthy Adult. (NCT02165046) | Intech Biopharm Ltd. | 2012-02-01 |
| Whole Body Vibration in Chronic Obstructive Pulmonary Disease (COPD) Patients (NCT01649310) | Universidade Federal de Pernambuco | 2012-02-01 |
| Impact of Family-based Pulmonary Rehabilitation (PR) on Patients With Chronic Obstructive Pulmonary Disease (COPD) and Their Family Members (NCT02048306) | Aveiro University | 2012-01-01 |
| Pharmacokinetic, Safety and Tolerability Study of Aclidinium/Formoterol Fixed Dose Combination and Formoterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (NCT01551888) | AstraZeneca | 2012-01-01 |
| Changes in Cardiac Function in COPD Patients After Administration of Budesonide/Formoterol (Symbicort®) Versus Placebo (NCT01760304) | Brigham and Women's Hospital | 2012-01-01 |
| Stepping up to Health - for Veterans With Chronic Obstructive Pulmonary Disease (COPD) (NCT01102777) | VA Office of Research and Development | 2011-12-01 |
| Efficacy and Safety Study of a Percussion Device to Mobilise Sputum From Respiratory Passage (NCT01480882) | Penang Hospital, Malaysia | 2011-12-01 |
| Development of an Optimal Antibiotic Regime for Long-term Therapy in Stable Chronic Obstructive Pulmonary Disease (COPD) (NCT01398072) | University College, London | 2011-12-01 |
| Detection and Characterization of COPD in Dairy Farmers (NCT02540408) | Centre Hospitalier Universitaire de Besancon | 2011-11-01 |
| Effects of Sulfur Thermal Water Inhalation on Airway Oxidative Stress in COPD Patients (NCT01664767) | Università degli Studi di Ferrara | 2011-11-01 |
| Efficacy and Safety of Aclidinium Bromide 400 µg BID (Twice a Day)Compared to Placebo in Patients With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (NCT01471171) | AstraZeneca | 2011-11-01 |
| Respiratory Rehabilitation Exercises in Older Adults With Acute Exacerbations of Chronic Obstructive Pulmonary Disease (NCT02329873) | Chest Hospital, Ministry of Health and Welfare, Taiwan | 2011-11-01 |
| Efficacy and Safety of Aclidinium Bromide 400 µg Compared to Placebo and to Tiotropium Bromide in Patients With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (NCT01462929) | AstraZeneca | 2011-11-01 |
| Innovative Pulmonary Solutions (IPS) System for Targeted Lung Denervation (NCT01483534) | Nuvaira, Inc. | 2011-10-01 |
| Long-term Efficacy and Safety of Aclidinium Bromide/Formoterol Fumarate Fixed-Dose Combination (NCT01462942) | AstraZeneca | 2011-10-01 |
| Efficacy and Safety Study of Tesamorelin in Chronic Obstructive Pulmonary Disease (COPD) Subjects With Muscle Wasting (NCT01388920) | Theratechnologies | 2011-09-01 |
| Efficacy of Indacaterol 150 µg Versus Formoterol (NCT01377428) | Novartis Pharmaceuticals | 2011-09-01 |
| Seoul National University Airway Registry (NCT02527486) | Seoul National University Hospital | 2011-09-01 |
| Efficacy and Tolerability Study in Severe Chronic Obstructive Pulmonary Disease (COPD) Patients (NCT01415518) | AstraZeneca | 2011-09-01 |
| Effectiveness of Interventions to Teach Respiratory Inhaler Technique (E-TRaIN) (NCT01426581) | University of Chicago | 2011-08-01 |
| Single Dose Study to Assess Efficacy and Safety of 4 Doses of LAS100977 in Chronic Obstructive Pulmonary Disease (COPD) Population (NCT01425814) | AstraZeneca | 2011-08-01 |
| Safety and Tolerability of Inhaled CHF 6001 in Healthy Volunteers (HV) (NCT01703052) | Chiesi Farmaceutici S.p.A. | 2011-07-01 |
| Single Leg Cycling in COPD: Knowledge Translation to Pulmonary Rehabilitation (NCT01930526) | West Park Healthcare Centre | 2011-07-01 |
| Efficacy and Tolerability of Symbicort as an add-on Treatment to Spiriva Compare With Spiriva Alone in Patients With Severe Chronic Obstructive Pulmonary Disease (COPD) (NCT01397890) | AstraZeneca | 2011-07-01 |
| Study Evaluating Preference, Satisfaction and Ease of Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD) Diagnosed Patients (NCT01385696) | Almirall, S.A. | 2011-06-01 |
| Bi-PAP vs Sham Bi-PAP on Pulmonary Function in Morbidly Obese Patients After Bariatric Surgery (NCT03438383) | Evangelismos Hospital | 2011-05-23 |
| Effects of TD-4208 on FEV1 in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT03064113) | Mylan Inc. | 2011-05-01 |
| Assessment of Risk in Chronic Airways Disease Evaluation (NCT01656421) | Cardiff University | 2011-05-01 |
| 12-week Open-label Evaluation of Efficacy and Safety of Indacaterol (NCT01232894) | Novartis Pharmaceuticals | 2011-03-01 |
| A Study to Evaluate the Integrated Dose Counter on an Albuterol Hydrofluoroalkane (HFA) Metered Dose Inhaler (MDI) (NCT01302587) | Teva Branded Pharmaceutical Products R&D, Inc. | 2011-03-01 |
| Tele Health Monitoring Service for Patients With Chronic Obstructive Pulmonary Disease (NCT02615795) | University of Aarhus | 2011-03-01 |
| QVA149 Versus Fluticasone/Salmeterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT01315249) | Novartis Pharmaceuticals | 2011-03-01 |
| A Continuation Study of the AeriSeal® System Administered at 3 to 4 Sites During a Single Treatment Session for Lung Volume Reduction in Patients With Advanced Emphysema (NCT01320566) | Aeris Therapeutics | 2011-03-01 |
| BEAM COPD: Breathing, Education, Awareness and Movement in Chronic Obstructive Pulmonary Disease (COPD) (NCT01551953) | Beth Israel Deaconess Medical Center | 2011-02-01 |
| Pulmonary Rehabilitation: Effects on Cognitive Functioning, Mood, Anxiety, and Quality of Life in Patients With COPD (NCT01682447) | Tilburg University | 2011-01-01 |
| Long Term Safety and Tolerability of QVA149 Versus Tiotropium in Japanese Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT01285492) | Novartis Pharmaceuticals | 2011-01-01 |
| Single Dose Lipopolysaccharide (LPS) Study In Healthy Volunteers (NCT01314885) | Pfizer | 2011-01-01 |
| Educational Interventions for Chronic Obstructive Pulmonary Disease (COPD) Self-management in Ethno-cultural Communities (NCT01474707) | University of British Columbia | 2011-01-01 |
| Outlook Quality of Life Intervention Study (NCT01044290) | VA Office of Research and Development | 2011-01-01 |
| Pharmaceutical Care for Chronic Obstructive Pulmonary Disease (COPD) Study. (NCT01260389) | University Hospital, Ghent | 2010-12-01 |
| Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant Suitability (NCT01241942) | University of North Carolina, Chapel Hill | 2010-12-01 |
| Safety Study of CTX-100 Inhalation Solution (Formerly ETX-100) (NCT00993707) | Turino, Gerard, M.D. | 2010-11-01 |
| Effect of Inhaled Steroids on Gene Expression in the Lungs - 2 (NCT00826748) | Weill Medical College of Cornell University | 2010-11-01 |
| Impact of Systemic Manifestations/Comorbidities on Clinical State, Prognosis, Utilisation of Health Care Resources in Patients With COPD (NCT01245933) | Philipps University Marburg | 2010-11-01 |
| Translating The GOLD COPD Guidelines Into Primary Care Practice (NCT01237561) | Memorial Hospital of Rhode Island | 2010-10-01 |
| The Study Will Evaluate the Effect of AZD8683 in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT01205269) | AstraZeneca | 2010-10-01 |
| The COPD Patient Management European Trial (COMET) (NCT01241526) | Air Liquide Santé International | 2010-09-01 |
| Safety and Efficacy Study of Glyco pMDI After Single and Repeated Administration (NCT01176903) | Chiesi Farmaceutici S.p.A. | 2010-08-01 |
| High Intensity Non-Invasive Positive Pressure Ventilation (HINPPV) (NCT01214200) | Philips Respironics | 2010-08-01 |
| Escalating and Cumulative-Dose Study of Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of A006 (NCT01189396) | Amphastar Pharmaceuticals, Inc. | 2010-07-01 |
| Effects of Mud Bath Therapy in Chronic Obstructive Pulmonary Disease (NCT01253941) | Fondazione Salvatore Maugeri | 2010-06-01 |
| A Trial to Reduce Readmissions Using Motivational Interviewing and Interactive Voice Response (NCT01855022) | Asante Health System | 2010-06-01 |
| Efficacy and Safety of Three Doses of Aclidinium Bromide Compared to Placebo and to an Active Comparator in Chronic Obstructive Pulmonary Disease (COPD) Patients. (NCT01120093) | AstraZeneca | 2010-05-01 |
| A Study Characterizing Pharmacodynamic Profiles in Subjects With Chronic Obstructive Pulmonary Disease (NCT01113593) | Dey | 2010-05-01 |
| Endothelial Function Study Before Cardiovascular Surgery (NCT01195064) | University Hospital, Grenoble | 2010-04-01 |
| To Determine the Relationship Between Baseline Reversibility and the Efficacy of Indacaterol (NCT01272362) | Novartis Pharmaceuticals | 2010-04-01 |
| Effect of Rosuvastatin Therapy in Patients With Stable Chronic Obstructive Pulmonary Disease (NCT00929734) | University Hospital, Akershus | 2010-03-01 |
| Disease Management in Asthma or Chronic Obstructive Pulmonary Disease (COPD) Patients (NCT01101126) | Sheba Medical Center | 2010-03-01 |
| A Prospective, Cohort Study of Hyperpolarized 3He MRI in Chronic Obstructive Pulmonary Disease (NCT02734368) | University of Pennsylvania | 2010-02-01 |
| Effect on Structural Changes in Airways, Measured by MSCT, of Twice Daily 60mg AZD9668 for 12 Weeks in Chronic Obstructive Pulmonary Disease (COPD) Patients (NCT01054170) | AstraZeneca | 2010-01-01 |
| Transnasal Insufflation (TNI) and Chronic Obstructive Pulmonary Disease (NCT01090544) | Helios Klinik Ambrock | 2009-12-01 |
| Activity of Inspiratory Muscles With the Use of Positive Pressure in Patients With Chronic Obstructive Pulmonary Disease (NCT01111487) | Hospital de Clinicas de Porto Alegre | 2009-11-01 |
| Efficacy and Safety of Twice Daily 60mg AZD9668 in COPD for 12 Weeks in Patients on Background Budesonide/Formoterol (NCT01023516) | AstraZeneca | 2009-11-01 |
| AeriSeal System for Lung Volume Reduction (NCT01051258) | Aeris Therapeutics | 2009-11-01 |
| Efficacy and Safety of Aclidinium Bromide at Two Dose Levels Versus Placebo Administered in Chronic Obstructive Pulmonary Disease (COPD) Patients (NCT01001494) | AstraZeneca | 2009-10-01 |
| Advanced Immunological Approach in COPD Exacerbation (NCT02417649) | Lallemand Pharma AG | 2009-09-01 |
| Effects of Pulmonary Rehabilitation on Respiratory Sounds in Patients With COPD (NCT02050711) | Aveiro University | 2009-09-01 |
| The Efficacy and Safety of Erdosteine in Chronic Obstructive Pulmonary Disease (COPD) (NCT01032304) | Edmond Pharma | 2009-08-01 |
| The Natural History of Gene Expression in the Lung Cells of Non-Smokers, Smokers and Ex-Smokers in Health and Disease (NCT00974064) | Weill Medical College of Cornell University | 2009-08-01 |
| The Efficacy and Safety of Salmeterol/Fluticasone Propionate vs Atropium/Albuterol in Patients COPD (NCT01243788) | Fudan University | 2009-07-01 |
| Effects of Neuromuscular Electrical Stimulation as an Adjunct to Exercise Training in Stable Chronic Obstructive Pulmonary Disease (COPD) (NCT01658046) | Hacettepe University | 2009-07-01 |
| Effect of Supplemental Vitamin D on Skeletal Muscle Function in Chronic Obstructive Pulmonary Disease (COPD) Patients (NCT00914810) | Minneapolis Veterans Affairs Medical Center | 2009-06-01 |
| Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease (NCT00877383) | Novartis Pharmaceuticals | 2009-04-01 |
| Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease (NCT00846586) | Novartis Pharmaceuticals | 2009-03-01 |
| ALK27-001: A Study of Trospium Inhalation Powder (TrIP)Administered to Subjects With COPD (NCT00801684) | Alkermes, Inc. | 2009-02-01 |
| Safety and Efficacy of Indacaterol Once Daily Versus Salmeterol Twice Daily in Chronic Obstructive Pulmonary Disease (COPD) (NCT00821093) | Novartis Pharmaceuticals | 2009-01-01 |
| Comparison of Dobutamine and Regadenoson Stress Cardiac Magnetic Resonance (MR) (NCT00763035) | Wake Forest University Health Sciences | 2009-01-01 |
| Efficacy and Safety of Indacaterol in Adults (40 Years and Above) With Chronic Obstructive Pulmonary Disease (COPD) (NCT00792805) | Novartis Pharmaceuticals | 2008-11-01 |
| Confirmatory Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT00794157) | Novartis Pharmaceuticals | 2008-11-01 |
| The Use of a Forecasting System for Predicting Exacerbations of COPD (NCT00788645) | AstraZeneca | 2008-08-01 |
| Endothelial Dysfunction in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD) (NCT01460082) | LudwLudwig Boltzmann Institute for COPD and Respiratory Epidemiology | 2008-08-01 |
| European Non-interventional Study in Chronic Obstructive Pulmonary Disease (COPD) Patients (NCT00722267) | AstraZeneca | 2008-07-01 |
| Lovastatin as a Potential Modulator of Apoptosis in Chronic Obstructive Pulmonary Disease (COPD) (NCT00700921) | National Jewish Health | 2008-04-01 |
| Acute Effects of Acu-Transcutaneous Electrical Nerve Stimulation (Acu-TENS) on Forced Expiratory Flow Volume in One Second (FEV1) and Blood β-Endorphin Level in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT00922051) | The Hong Kong Polytechnic University | 2008-03-01 |
| A Crossover Study to Determine the Effect on Lung Function of Indacaterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD), Using Tiotropium as an Active Control (NCT00615459) | Novartis | 2008-02-01 |
| Aclidinium/Formoterol Fixed Combination Dose Finding Study (NCT00626522) | AstraZeneca | 2008-02-01 |
| Study of Indacaterol Dosed in the Evening in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT00615030) | Novartis | 2008-01-01 |
| A Research Study of MK0633 in Patients With Chronic Obstructive Pulmonary Disease (COPD)(0633-009)(COMPLETED) (NCT00418613) | Merck Sharp & Dohme LLC | 2008-01-01 |
| Tolerability/Safety and Efficacy of Inhaled AZD4818 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (NCT00629239) | AstraZeneca | 2008-01-01 |
| Efficacy and Safety of QVA149 in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT00570778) | Novartis Pharmaceuticals | 2007-12-01 |
| An Intervention to Improve Function in Severe Cardiopulmonary Illness (NCT00467298) | VA Office of Research and Development | 2007-12-01 |
| Effects of Advair® in Outpatients With Chronic Obstructive Pulmonary Disease (COPD) Acute Exacerbation (NCT00531791) | Laval University | 2007-11-01 |
| Safety and Tolerability of QVA149 (Indacaterol/Glycopyrrolate) Compared to Placebo and to Indacaterol in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD) (NCT00558285) | Novartis | 2007-11-01 |
| Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) Using Salmeterol as Active Control (NCT00567996) | Novartis | 2007-11-01 |
| Effect of Supplementary Vitamins on Oxidant Gene Expression in the Lungs of Healthy Smokers (NCT00565214) | Weill Medical College of Cornell University | 2007-09-01 |
| Evaluation of Onset of Effect in Patients With Severe Chronic Obstructive Pulmonary Disease (COPD) Treated With Symbicort® Compared to Seretide® (NCT00542880) | AstraZeneca | 2007-09-01 |
| Patient Education in Patients With Chronic Obstructive Pulmonary Disease (COPD) - Effect and Costs (NCT00705302) | Norwegian University of Science and Technology | 2007-09-01 |
| A Study to Examine the Effect of Particle Size on Bioequivalence and Bioavailability (NCT00517543) | GlaxoSmithKline | 2007-08-01 |
| Safety and Tolerability of 28 Days Treatment With Glycopyrronium Bromide (NVA237) (100 or 200 µg Once a Day) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (NCT00510510) | Novartis | 2007-08-01 |